Metabolism of endocannabinoids

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Endocannabinoids belong to a group of ester, ether and amide derivatives of fatty acids, which are endogenous ligands of receptors CB1, CB2, TRPV1 and GPR55 that are included in the endocannabinoid system of the animal organism. The best known endocannabinoids are: N-arachidonylethanolamide called anandamide (AEA) and 2-arachidonoylglycerol (2-AG). They occur in all organisms, and their highest level is observed in the brain. In this review the mechanisms of synthesis and degradation of both AEA and 2-AG are shown. Endocannabinoids are synthesized from phospholipids (mainly phosphatidylethanolamine, phosphatidylcholine, and phosphatidylinositol) located in the cell membrane. As a result of arachidonic acid transfer from phosphatidylcholine to phosphatidylethanolamine, N-arachidonoyl phosphatidylethanolamine is formed, which is hydrolyzed to AEA by phospholipase D, C and A2. However, 2-AG is formed during the hydrolysis of phosphatidylinositol catalyzed mainly by DAGL. The primary role of endocannabinoids is the activation of cannabinoid receptors. Both AEA and 2-AG are primarily agonists of the CB1 receptor and to a lower degree CB2 and TRPV1r eceptors, but 2-AG has stronger affinity for these receptors. Through activation of receptors, endocannabinoids affect cellular metabolism and participate in the metabolic processes by receptor-independent pathways. Endocannabinoids which are not bound to the receptors are degraded. The main enzymes responsible for the hydrolysis of AEA and 2-AG are FAAH and MAGL, respectively. Apart from hydrolytic degradation, endocannabinoids may also be oxidized by cyclooxygenase-2, lipoxygenases, and cytochrome P450. It has been shown that the metabolites of both endocannabinoids also have biological significance.

Authors and Affiliations

Michał Biernacki, Elżbieta Skrzydlewska

Keywords

Related Articles

Aktywność osi podwzgórze-przysadka-tarczyca (HPT) i funkcjonowanie mięśnia sercowego w warunkach deficytu energetycznego

Często powtarzane uogólnienie, że restrykcje energetyczne wpływają korzystnie na działanie układu sercowo-naczyniowego, nie jest w pełni prawdziwym. Stosowanie diet o niskiej wartości energetycznej zmienia bowiem funkcjo...

Funkcja mitochondriów w utrzymaniu płodności żeńskiej

Komórki żeńskiej linii płciowej są źródłem genomu mitochondrialnego dla całego organizmu, zarówno u osobników płci męskiej jak i żeńskiej. W komórkach tych, będących źródłem i nośnikiem mitochondrialnego DNA dla przyszły...

Rezystyna – czynnik patogenetyczny czy biomarker zaburzeń metabolicznych i zapalenia?

Choroby układu krążenia stanowią obecnie najczęstszą przyczynę zgonów w Polsce, a częstość ich występowania stale wzrasta. Jest to związane z epidemią otyłości oraz towarzyszącą jej insulinoopornością i cukrzycą typu 2....

Individualization of anticancer therapy; molecular targets of novel drugs in oncology

Deregulation of cellular signal transduction, caused by gene mutations, has been recognized as a basic factor of cancer initiation, promotion and progression. Thus, the ability to control the activity of overstimulated s...

Beta-blockers and statins in the context of asthma

Asthma is a disease with a complex pathogenesis and differentiated clinical picture with airway inflammation in its background. Many cells and cell-released substances are engaged in the course of the disease. The basic...

Download PDF file
  • EP ID EP220827
  • DOI -
  • Views 132
  • Downloads 0

How To Cite

Michał Biernacki, Elżbieta Skrzydlewska (2016). Metabolism of endocannabinoids. Advances in Hygiene and Experimental Medicine, 70(), 830-843. https://europub.co.uk/articles/-A-220827